AlconALC +2.74%71 Days Payable is 71.28 as of Mar. 2026, which is 0% below its 10-year median of 71.29. GuruFocus rates ALC with a GF Score™ of 71/100 and a GF Value™ of $93.13 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Alcon ranks better than 51.19% on this metric.
Alcon's average Accounts Payable for the
three
months ended in Mar. 2026 was $923 Mil. Alcon's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $1,181 Mil.
Hence, Alcon's Days Payable for the
three
months ended in Mar. 2026 was 71.28.
The historical rank and industry rank for Alcon's Days Payable or its related term are showing as below:
ALC'
s Days Payable Range Over the Past 10 Years
Min: 58.74 Med: 71.29 Max: 87.66
Current: 70.22
During the past 10 years, Alcon's highest Days Payable was 87.66. The lowest was 58.74. And the median was 71.29.
ALC's Days Payable is ranked better than 51.19% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs ALC: 70.22
Alcon's Days Payable
increased
from Mar. 2025 (67.60) to Mar. 2026 (71.28).
It may suggest that Alcondelayed paying its suppliers.
Alcon Days Payable Related Terms
Alcon Days Payable Historical Data
* Premium members only.
The historical data trend for Alcon's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Alcon's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcon Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alcon's Days Payable distribution charts can be found below:
* The bar in red indicates where Alcon's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Alcon's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcon (ALC) has a Days Payable of 71.28 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alcon and its competitors. This is near median its historical median of 71.29. Over the past decade, Alcon's Days Payable has ranged from 58.74 to 87.66. According to the industry distribution chart, Alcon ranks #388 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 48.8%.
Is Alcon's Days Payable too high?
Alcon's current Days Payable of 71.28 is near median its 10-year median of 71.29. Over the past 10 years, this metric has ranged from a low of 58.74 to a high of 87.66. The Medical Devices & Instruments industry median Days Payable is 67.87. Alcon's value of 71.28 is 5% above this industry median. Based on the distribution chart, Alcon ranks #388 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Alcon has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Alcon ranks #388 out of 795 companies for Days Payable. This puts Alcon in the upper half of its industry. The industry median Days Payable is 67.87. Alcon's value of 71.28 is 5% above this benchmark. Historically, Alcon's own Days Payable has ranged from 58.74 to 87.66 over the past decade. While the company's 10-year median is 71.29 vs. the industry median of 67.87, Alcon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcon's current Days Payable of 71.28 is 5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alcon and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcon's current Days Payable is 71.28, which is near median its own 10-year median of 71.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is $93.13, compared to a current price of $67.93 — trading 27.1% below its estimated fair value. The current Days Payable is 71.28, which is near median its 10-year median of 71.29 and 5% above the Medical Devices & Instruments industry median of 67.87. Alcon's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Alcon (ALC), the current Days Payable is 71.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alcon (ALC) Overvalued in 2026?
Based on GuruFocus' analysis, Alcon stock appears to be undervalued.
The current stock price of $67.93 is trading 27.1% below its estimated GF Value™ of $93.13.
GuruFocus considers Alcon to be Modestly Undervalued.
Key valuation signals for ALC:
Days Payable: 71.28 (near median its 10-year median of 71.29)
GF Value™: $93.13 vs. price of $67.93 (27.1% below fair value)
Industry Position: 5% above the Medical Devices & Instruments median (#388 of 795)
No single metric tells the full story. See the ALC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
71GF Score
Get the complete analysis for ALC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALC has been successfully added to your 
